Clinical Trials on Healthy Female Subjects

Total 40239 results

Merz Pharmaceuticals GmbH

Completed

Evaluation of Dose-Dependent Repeated-Dose Neramexane Effects on Cardiac Repolarisation (QT/QTc Interval Duration): Electrocardiogram (ECG) Study in Healthy Adult Subjects

Healthy Subjects

Germany
Merz Pharmaceuticals GmbH

Completed

Open, Single Center, Three Periods, Fixed Sequence Design Study on the Effects of Clopidogrel Co-administration on the Pharmacokinetics of Neramexane

Healthy Subjects

Germany
GlaxoSmithKline

Completed

Study of Safety, Blood Levels and Brain Receptor Occupancy of GSK598809 Using PET Imaging in Health Males.

Healthy Subjects

Canada
Hvidovre University Hospital

Completed

Glucose-dependent Insulinotropic Polypeptide (GIP) and Lipid Metabolism

Healthy Subjects

Denmark
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Single Doses of ILV-095 in Healthy Subjects

Healthy Subjects

United States
University Hospital, Strasbourg, France

Completed

Exploring the Effects of Diazepam and Lorazepam (ibid)

Healthy Subjects

France
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating The Effect of Bosutinib (SKI-606) On Cardiac Repolarization (Rhythms Of The Heart)

Healthy Subjects

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Pharmacokinetics of the Potential Drug Interaction Between CYP2C9 Inhibitor and Substrate

Healthy Subjects
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Safety, Pharmacokinetics (PK), and Pharmacodynamices (PD) of HSD-016

Healthy Subjects

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating BLI-489 and Piperacillin in Healthy Subjects

Healthy Subjects

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Pharmacokinetics of Tigecycline in Human Bone

Healthy Subjects

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Safety and Pharmacokinetics (PK) of Ascending Single IV Doses of ERB-257 in Healthy Japanese Males

Healthy Subjects

Japan
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Single Ascending Dose Study of the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of HSD-016

Healthy Subjects

Japan
GlaxoSmithKline

Completed

To Study And Compare Bioavailability And Safety Of Four Different Formulations Of The Study Drug

Healthy Subjects

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Comparing 2 Different Formulations of Pantoprazole in Healthy Adults.

Healthy Subjects
Technische Universität Dresden

Completed

Comparison of Vascular Effects After Therapy With Irbesartan and Atorvastatin.

Healthy Subjects

Germany
AdjuTec Pharma AS
CTC Clinical Trial Consultants AB

Not yet recruiting

A First-in-human Trial to Evaluate Safety, Tolerability, and Pharmacokinetics of APC148 in Healthy Adults

Healthy Subjects

Sweden
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Recruiting

A Study of HS-10501 Tablets in Healthy Subjects

Healthy Subjects

China
Shouyao Holdings (Beijing) Co. LTD

Not yet recruiting

A Study to Evaluate the Effect of Itraconazole and Rifampicin on the Pharmacokinetics of SY-5007 in Healthy Subjects

Healthy Subjects

China
Alebund Pharmaceuticals

Not yet recruiting

A Study to Evaluate the Safety, Tolerability, PK and PD of AP303 in Healthy Chinese Participants

Healthy Subjects
Abbisko Therapeutics Co, Ltd

Recruiting

A Clinical Trial to Evaluate the Relative Bioavailability of New and Old ABSK-011 Capsules

Healthy Subjects

China
Bio-innova Co., Ltd

Not yet recruiting

Sildenafil 100 mg Tablets Relative to Viagra 100 mg Tablets

Healthy Subjects
Bio-innova Co., Ltd

Not yet recruiting

Dutasteride Soft Capsule 0.5 mg Relative to Avodart 0.5 mg Soft Capsule

Healthy Subjects
Bio-innova Co., Ltd

Not yet recruiting

Drospirenone (3 mg) + Ethinyl Estradiol (0.03 mg) Tablets Relative to Yasmin®

Healthy Subjects
Bio-innova Co., Ltd

Not yet recruiting

Dapagliflozin Tablet 10 mg Relative to Forxiga® Tablets 10 mg (DAP-030-23)

Healthy Subjects
Bio-innova Co., Ltd

Not yet recruiting

Ticagrelor Tablets 90 mg Relative to Originator Ticagrelor Tablets 90 mg (TIC-025-23)

Healthy Subjects
Jacobio Pharmaceuticals Co., Ltd.

Recruiting

A Clinical Trial to Evaluate JAB-21822 Drug-drug Interactions in Healthy Subjects

Healthy Subjects

China
Cardenal Herrera University

Recruiting

Intramuscular Temperature on the Echo-textural Characteristics

Healthy Subjects

Spain
Innovent Biologics (Suzhou) Co. Ltd.

Not yet recruiting

Safety and Tolerance Study of IBI355 in Health Volunteers

Healthy Subjects

China
Vigonvita Life Sciences

Recruiting

Study of the Safety, Tolerability, and Pharmacokinetics of LV232 Capsules in Chinese Healthy Volunteers

Healthy Subjects

China
ImmunityBio, Inc.

Recruiting

Single Center Study Of N-803 Stimulation On Expansion, Enrichment, Proliferation Of Natural Killer Cells Collected By Apheresis

Healthy Subjects

United States
Edgewise Therapeutics, Inc.

Recruiting

A Study of EDG-7500 in Healthy Adults

Healthy Subjects

United States
Centre Hospitalier Universitaire de Liege

Recruiting

Peri-Implant Soft Tissue Integration in Humans: Influence of Material

Healthy Subjects

Belgium
Shanghai Vinnerna Biosciences Co., Ltd.
Sponsor GmbH

Recruiting

The Mass Balance Study of [14C]JT001

Healthy Subjects

China
Celltrion

Recruiting

Compare the Auto-injector and Pre-filled Syringe of CT-P47 in Healthy Subjects

Healthy Subjects

Korea, Republic of
Dizal Pharmaceuticals

Recruiting

Drug-drug Interactions Between AZD4205 and Itraconazole/Carbamazepine

Healthy Subjects

United States
Celltrion

Recruiting

A Study to Compare the Pharmacokinetics and Safety of CT-P47 and RoActemra in Healthy Subjects

Healthy Subjects

Korea, Republic of
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Not yet recruiting

A Study of SYHA1805 in Healthy Subjects

Healthy Subjects
CSPC Ouyi Pharmaceutical Co., Ltd.

Recruiting

The Safety, Tolerability, and Pharmacokinetics of SYHX1901 Tablets in Chinese Healthy Subjects

Healthy Subjects

China
Indiana University
Purdue University

Recruiting

Effect of Stimulation on the Vagus Nerve

Healthy Subjects

United States
Russian Academy of Medical Sciences
State Scientific Centre of Coloproctology, Russian Federation; Federal Research...

Recruiting

Normative Metrics of High-Resolution Anorectal Manometry With the Use of Solid-State Catheter in a Healthy Russian Cohort

Healthy Subjects

Russian Federation
Örebro University, Sweden
Region Örebro County

Active, not recruiting

Spatial Analysis of the Intestinal Microbiota in Healthy Subjects

Healthy Subjects

Sweden
KBP Biosciences
Parexel

Completed

Study of KBP-7072 in Healthy Male and Female Subjects

Healthy Subjects

United States
Chong Kun Dang Pharmaceutical

Completed

Evaluation of the Safety and Tolerability of CKD-508 in Healthy Subjects

Healthy Subjects

United Kingdom
Chrysea Labs Lda

Active, not recruiting

Metabolic Responses to Spermidine Supplementation.

Healthy Subjects

United States
VectivBio AG

Completed

Evaluation of Apraglutide on Gastric Emptying

Healthy Subjects

Netherlands
Guangzhou JOYO Pharma Co., Ltd

Completed

Evaluation of Safety, Tolerability, PK/PD, and Metabolism of Single-Dose Singletine(DC407) in Adults

Healthy Subjects

China
Seoul National University Hospital
Ensol Biosciences, Inc.

Completed

To Evaluate the Safety, Tolerability, and Pharmacokinetics After Subcutaneous Administration of C1K in Healthy Subjects

Healthy Subjects

Korea, Republic of
UNEEG Medical A/S

Completed

Safety and Performance of Short- and Long-term Baseplates for Attaching the Marco Recorder

Healthy Subjects

Denmark
Innovent Biologics (Suzhou) Co. Ltd.

Completed

A Study of IBI351 in Healthy Subjects

Healthy Subjects

China

3

Subscribe